Antonio Gotto

Last updated
Gotto in October 2009 Antonio Gotto.jpg
Gotto in October 2009

Antonio M. Gotto, Jr. was Dean of Weill Medical College of Cornell University. He was succeeded by Laurie H. Glimcher in January 2012. [1] Prior to his appointment in 1997, Gotto was chairman of the department of internal medicine at Baylor College of Medicine for 20 years, where he collaborated extensively with Michael DeBakey. Gotto is best known for his research into blood lipids. As administrator, he presided over an enormous growth at Cornell, an affiliation with Houston Methodist Hospital when it separated from Baylor, and a deepening of Cornell's longtime affiliation with New York Hospital following its merger with Columbia Presbyterian to form the New York-Presbyterian Hospital.


Gotto obtained his bachelor's degree from Vanderbilt University in 1957. [2] He then attended Oxford University as a Rhodes Scholar where received D.Phil. degree in 1961. [2] He subsequently graduated from Vanderbilt's medical school in 1965. [2] In the field of atherosclerosis, his basic science research interests include clinical disorders of lipid transport and the structure, metabolism, and function of lipoproteins and apolipoproteins. He and his associates were the first to achieve complete synthesis of a plasma apolipoprotein (apo C-I); they also determined the complete cDNA and amino acid sequence of apo B-100, one of the largest proteins ever sequenced and a key protein in atherosclerosis. Gotto has played a leading role in several landmark clinical trials demonstrating that cholesterol-lowering drug treatment can reduce the risk for heart disease.

A lifelong supporter of educational efforts aimed at cardiovascular risk reduction, Gotto has been National President of the American Heart Association and President of the International Atherosclerosis Society. He is a member of the Institute of Medicine and the American Academy of Arts and Sciences and a recipient of many honors. Gotto has contributed more than 500 scholarly articles and books to the medical literature, and he is coauthor of a series of books (The Living Heart series) that explain the origins and treatment of cardiovascular disease to the general public. Gotto has been on the editorial boards of numerous academic publications, including a senior editor of The Medical Roundtable, Cardiovascular Edition, a peer-reviewed journal publishing expert roundtable discussions on compelling topics.

He lives in New York City and Houston, Texas.

Related Research Articles

High-density lipoprotein (HDL) is one of the five major groups of lipoproteins. Lipoproteins are complex particles composed of multiple proteins which transport all fat molecules (lipids) around the body within the water outside cells. They are typically composed of 80–100 proteins per particle and transporting up to hundreds of fat molecules per particle.

Low-density lipoprotein One of the five major groups of lipoprotein

Low-density lipoprotein (LDL) is one of the five major groups of lipoprotein which transport all fat molecules around the body in the extracellular water. These groups, from least dense to most dense, are chylomicrons, very low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), low-density lipoprotein and high-density lipoprotein (HDL). LDL delivers fat molecules to cells. LDL is involved in atherosclerosis, a process in which it is oxidized within the walls of arteries.

Michael DeBakey American cardiac and vascular surgeon and innovator

Michael Ellis DeBakey was a Lebanese-American cardiac surgeon and vascular surgeon, scientist and medical educator who became the chancellor emeritus of Baylor College of Medicine in Houston, Texas, director of the Houston Methodist DeBakey Heart & Vascular Center, and senior attending surgeon at Houston Methodist Hospital in Houston, with a career spanning 75 years.

The NewYork-Presbyterian Hospital is a nonprofit academic medical center in New York City affiliated with two Ivy League medical schools: Columbia University Vagelos College of Physicians and Surgeons and Weill Cornell Medicine. It is composed of two distinct medical centers, Columbia University Irving Medical Center and Weill Cornell Medical Center. As of 2020, the hospital is ranked as the 4th best hospital in the United States and 1st in the New York City metropolitan area by U.S. News & World Report. The hospital has around 20,000 employees and 2,678 beds in total, and is one of the largest hospitals in the world.

Apolipoprotein class of protein

Apolipoproteins are proteins that bind lipids to form lipoproteins. They transport lipids in blood, cerebrospinal fluid and lymph.

Hyperlipidemia is abnormally elevated levels of any or all lipids or lipoproteins in the blood. Hyperlipidemia is an umbrella term that refers to acquired or genetic disorders that result in high levels of lipids circulating in the blood. This disease is usually chronic and requires ongoing medication to control blood lipid levels.

Apolipoprotein B protein-coding gene in the species Homo sapiens

Apolipoprotein B (ApoB) is a protein that in humans is encoded by the APOB gene.

Apolipoprotein A-1 Milano is a naturally occurring mutated variant of the apolipoprotein A1 protein found in human HDL, the lipoprotein particle that carries cholesterol from tissues to the liver and is associated with protection against cardiovascular disease. ApoA1 Milano was first identified by Dr. Cesare Sirtori in Milan, who also demonstrated that its presence significantly reduced cardiovascular disease, even though it caused a reduction in HDL levels and an increase in triglyceride levels.

Weill Cornell Medicine, officially the Joan & Sanford I. Weill Medical College of Cornell University, is the biomedical research unit and medical school of Cornell University, a private Ivy League university. The medical college is located at 1300 York Avenue, on the Upper East Side of Manhattan in New York City, along with the Weill Cornell Graduate School of Medical Sciences. The college is named for benefactor and former Citigroup chairman Sanford Weill.

Lipoprotein(a) human protein (annotated by UniProtKB/Swiss-Prot P08519)

Lipoprotein(a) is a low-density lipoprotein variant containing a protein called apolipoprotein(a). Genetic and epidemiological studies have identified lipoprotein(a) as a risk factor for atherosclerosis and related diseases, such as coronary heart disease and stroke.

Apolipoprotein A1 mammalian protein found in Homo sapiens

Apolipoprotein A1 is a protein that in humans is encoded by the APOA1 gene. It has a specific role in lipid metabolism. The text in a 2014 report suggested that APOA1 mRNA is regulated by endogenously expressed antisense RNA.

Apolipoprotein C3 protein-coding gene in the species Homo sapiens

Apolipoprotein C-III also known as apo-CIII is a protein that in humans is encoded by the APOC3 gene. Apo-CIII is secreted by the liver as well as the small intestine, and is found on triglyceride-rich lipoproteins such as chylomicrons, very low density lipoprotein (VLDL), and remnant cholesterol.,

APOA2 protein-coding gene in the species Homo sapiens

Apolipoprotein A-II is a protein that in humans is encoded by the APOA2 gene.

The Rogosin Institute is an independent, not-for-profit treatment and research center with facilities throughout New York City that treat patients with kidney disease, including dialysis and kidney transplantation; lipid disorders; and hypertension. It is affiliated with NewYork-Presbyterian Hospital, Weill Cornell Medical College and is a leader in research programs for cancer and diabetes.

James K. Min American physician

James K. Min is an American physician, a Professor of Radiology at Weill Cornell Medical College, and Director of the Dalio Institute of Cardiovascular Imaging at NewYork-Presbyterian Hospital/Weill-Cornell Medical Center. Prior to this, he held the title of Professor of Medicine at both Cedars Sinai Medical Center in Los Angeles, CA and David Geffen UCLA School of Medicine, Los Angeles, CA. He is an expert in Cardiovascular Imaging and has led numerous multi-center international clinical trials. He has been studying clinical utility and coronary artery diseases for over ten years. During his work at UCLA and NewYork-Presbyterian Hospital/Weill-Cornell Medical Center, Dr. Min published over 250 papers on Cardiac CT and Coronary Artery Disease.

Wolfgang Patsch is an Austrian physician, specialized in internal medicine/laboratory medicine and a professor in the Department of Pharmacology and Toxicology at the Paracelsus Private Medical University of Salzburg. He is known for his work in the fields of atherosclerosis, common metabolic disorders such as obesity, insulin resistance and type-2 diabetes and neurodegenerative disorders.

Michael J. Reardon is an American cardiac surgeon and medical researcher. He is known for his work in heart autotransplantation for malignant heart tumors, an operation in which the surgeon removes the patient's heart, cuts out the malignant tumor, and reimplants the heart back in the patient's chest. He performed the first successful heart autotransplantation for a cancerous heart tumor in 1998.

Jan Leslie Breslow is an American physician and medical researcher who studies atherosclerosis. As of 2017, he is Frederick Henry Leonhardt Professor at Rockefeller University and directs the university's Sackler Center for Biomedicine and Nutrition Research.

William A. Zoghbi is a Lebanese-American cardiologist. He is Professor of Medicine at Weill Cornell Medical College and in the Houston Methodist Institute for Academic Medicine, in Houston Texas. He holds the Elkins Family Distinguished Chair in Cardiac Health at the Houston Methodist DeBakey Heart & Vascular Center. Zoghbi is the Chairman of the Department of Cardiology at Houston Methodist Hospital. He is a Master of the American College of Cardiology and served as its president in 2012.

Bruce B. Lerman is a cardiologist. He is the Hilda Altschul Master Professor of Medicine at Weill Cornell Medical College, and Chief of the Division of Cardiology and Director of the Cardiac Electrophysiology Laboratory at Weill Cornell Medicine and the New York Presbyterian Hospital.

References

  1. ↑ Hartocollis, Anemona (September 7, 2011). "Harvard Researcher Chosen as New Dean of Weill Cornell Medical College". The New York Times. Retrieved September 9, 2011.
  2. 1 2 3 Gotto, Antonio M - VIVO - Cornell University (2004). Retrieved September 15, 2020


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.